DUSP14 and systemic lupus erythematosus: Therefore, enhancement/activation of DUSP14 or DUSP14 upstream molecules is a potential modality for the attenuation of autoimmune diseases such as systemic lupus erythematosus (SLE) (Chuang and Tan, 2019).